NCT06622356

Brief Summary

The study was a clinical retrospective study designed to investigate risk factors for long-term recurrent pain after PLIF in patients with lumbar degenerative disease and to improve patient outcomes

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
452

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 20, 2024

Completed
5 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 25, 2024

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

September 28, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 28, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 2, 2024

Completed
Last Updated

October 2, 2024

Status Verified

September 1, 2024

Enrollment Period

5 days

First QC Date

September 28, 2024

Last Update Submit

October 1, 2024

Conditions

Keywords

Lumbar Degenerative diseasePLIFSarcopeniaSagittal balanceMachine learningSVMCross Validation

Outcome Measures

Primary Outcomes (1)

  • SAS(Pain rating scale)

    The visual analogue scale (VAS) was employed to determine the patient's perception of lower back pain or lower limb pain prior to surgery, as well as 12-18 months after surgery. (0-10 scale, with 0 being painless and 10 being the most painful)

    12-18 months after surgery

Study Arms (2)

Rehabilitation Group

Rehabilitation Group (n = 268): mild/non pain group with VAS\<3 at 12-18 months after PLIF。The study was retrospective and did not design an intervention

Other: MRI with Eovist

Recurrent pain group

Recurrent pain group (n = 184): recurrent pain group with VAS≥3 at 12-18 months after PLIF

Other: MRI with Eovist

Interventions

The study was retrospective and did not design an intervention

Recurrent pain groupRehabilitation Group

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This study retrospectively reviewed 452 patients suffering from degenerative lumbar spinedisorders in our institute between January 2019 and February 2023. The patients were separated into Recurrent pain group and Rehabilitation Group. Recurrent pain group (n = 268): mild/non pain group with VAS\<3 at 12-18 months after PLIF;Rehabilitation Group (n = 184): recurrent pain group with VAS≥3 at 12-18 months after PLIF.

You may qualify if:

  • confirmed diagnosis of lumbar degenerative disease (spinal stenosis, disc herniation with lumbar instability, and lumbar spondylolisthesis), with no significant symptomatic relief after conservative treatment for more than 3 months, and in need of surgical intervention;
  • lumbar spinal fusion surgical treatment with PLIF;
  • grouping based on the presence or absence of a lumbar or limb pain with VAS ≥3 at the 12-18 month postoperative follow-up;
  • observational indicators including individual factors, surgical factors, spine-pelvis sagittal balance parameters, and paravertebral muscle parameters.

You may not qualify if:

  • (1) those with a history of lumbar spine trauma, inflammation, tumor, or surgery; (2) those with congenital or acquired severe lumbar vertebral deformity; (3) those with severe neurological dysfunction; (4) those with incomplete baseline and follow-up data.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical record system and imaging system of the First Affiliated Hospital of Suzhou University

Suzhou, Jiangsu, 215006, China

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Biological samples were not designed for this study

MeSH Terms

Conditions

Intervertebral Disc DisplacementSarcopenia

Interventions

Magnetic Resonance Spectroscopygadolinium ethoxybenzyl DTPA

Condition Hierarchy (Ancestors)

Spinal DiseasesBone DiseasesMusculoskeletal DiseasesHerniaPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsMuscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophySigns and Symptoms

Intervention Hierarchy (Ancestors)

Spectrum AnalysisChemistry Techniques, AnalyticalInvestigative Techniques

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Orthopedic surgeon, First Affiliated Hospital of Suzhou University, Jiangsu Province, China

Study Record Dates

First Submitted

September 28, 2024

First Posted

October 2, 2024

Study Start

September 20, 2024

Primary Completion

September 25, 2024

Study Completion

September 28, 2024

Last Updated

October 2, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will share

Before January 1,2025;in the form of paper.The original data of the trial will be uploaded to Genome Sequence Archive (GSA) (ngdc.cncb.ac.cn)

Locations